A Pentacyclic Aurora Kinase Inhibitor (AKI-001) with High in Vivo Potency and Oral Bioavailability

Author:

Rawson Thomas E.1,Rüth Matthias1,Blackwood Elizabeth1,Burdick Dan1,Corson Laura1,Dotson Jenna1,Drummond Jason1,Fields Carter1,Georges Guy J.1,Goller Bernhard1,Halladay Jason1,Hunsaker Thomas1,Kleinheinz Tracy1,Krell Hans-Willi1,Li Jun1,Liang Jun1,Limberg Anja1,McNutt Angela1,Moffat John1,Phillips Gail1,Ran Yingqing1,Safina Brian1,Ultsch Mark1,Walker Leslie1,Wiesmann Christian1,Zhang Birong1,Zhou Aihe1,Zhu Bing-Yan1,Rüger Petra1,Cochran Andrea G.1

Affiliation:

1. Departments of Small Molecule Drug Discovery, Cell Cycle and Global Regulators, Translational Oncology, and Protein Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, and Departments of Medicinal Chemistry, Cell Biology, and HTS and Biochemistry, Pharma Research, Roche Diagnostics GmbH, D-82372 Penzberg, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3